electric cell-to-cell communication, which creates conduction heterogeneity as a substrate for the maintenance of AF. 10 Here, we performed candidate gene studies to identify rare variants, under the hypothesis that these variants pose an AF risk in these probands. In addition, to determine the functional significance of these variants, we performed cellular electrophysiological studies and in silico prediction analysis.
Methods
Detailed description of Methods is provided in the Data Supplement.
Study Subjects
The study subjects were recruited from multiple hospitals in Japan. Lone AF was defined as AF occurring in individuals aged <65 years, who did not present with hypertension, overt structural heart disease, myocardial infarction, congestive heart failure, or thyroid dysfunction. Two hundred fifty healthy Japanese subjects with no history of the cardiovascular disease described above were also included in this study. Data from the National Heart, Lung, and Blood Institute Exome Sequencing Project Exome Variant Server (EVS) 11 and the Exome Aggregation Consortium (ExAC) data and browser 12 were used as reference groups.
The study observed the principles outlined in the Declaration of Helsinki and was approved by the Ethics Committee for Medical Research at our institution. All study patients provided written informed consent before registration.
DNA Isolation and Mutation Analysis and Genotype-Phenotype Relationships
Genomic DNA was extracted from peripheral blood leukocytes using standard methods. High-resolution melting curve analysis was used to screen KCNA5, KCNQ1, KCNH2, SCN5A, SCN1B, SCN2B, SCN3B, KCNE1, KCNE2, KCNJ5, GJA5, and NPPA using a LightScanner (BioFire Defense, Salt Lake City, UT). Samples in which the melting curve deviated from the wild-type (WT) control were subjected to DNA sequencing using an ABI PRISM 310 Genetic Analyzer. The relationship between the clinical phenotype (AF) and the genotype was determined for probands and their relatives in whom a variant was identified.
Plasmid Constructs and Electrophysiology
Mutant cDNAs were constructed using an overlap extension strategy 13 or by using the QuikChange XL Site-Directed Mutagenesis Kit (Agilent Technologies, Santa Clara, CA). CHO-K1 or HEK293 cells were transiently transfected with WT or mutant cDNA, using an X-tremeGENE 9 DNA Transfection Reagent (Roche Applied Science, Penzberg, Germany). Cells were cotransfected with the same amount of green fluorescent protein as each ion-channel cDNA.
Cells displaying green fluorescence at 48 to 72 hours after transfection were subjected to electrophysiological analysis. Potassium or sodium currents were studied using the whole-cell patch clamp technique with an amplifier, Axopatch-200B (Molecular Devices, Sunnyvale, CA), at room temperature. The voltage clamp protocols are described in the figures. Data were acquired using pCLAMP software (version 9; Molecular Devices, Sunnyvale, CA). Data acquisition and analysis were performed using a Digidata 1321 A/D converter and pCLAMP8.2 software (Molecular Devices, Sunnyvale, CA).
In Silico Prediction Analysis
A total of 5 prediction tools were applied to predict the pathogenicity of lone AF-associated variants: the PolyPhen algorithm, 14 Grantham chemical scores, 14 Sorting Intolerant From Tolerant analysis, 14 the Protein Variation Effect Analyzer, 15 and Combined Annotation Dependent Depletion (CADD).
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Statistical Analysis
Pooled electrophysiological data were expressed as mean±SE. The minor allele frequency (MAF) in the AF cohort was compared with the MAF from the EVS and the ExAC using Fisher exact test in 2×2 tables. Two-tailed Student t test was used for the single comparisons between the 2 groups. One-way ANOVA, followed by a Bonferroni post hoc test, was used to analyze data with unequal variance among 3 groups. Two-way repeated-measures ANOVA was used to adjust for multiple comparisons across the different values of membrane potentials. A value of P<0.05 was considered as statistically significant. Statistical analysis was performed using JMP Pro 11.0.0 (SAS Institute Inc, NC) and Origin 9.0 (OriginLab, Northampton, MA).
Results
Clinical Characteristics and Molecular Genetic Analysis of the Study Cohort
Of the 90 patients with lone AF that were enrolled, 26 subjects (29%) had a family history of AF in at least 1 first-degree relative ( Table 1 ). The study subjects had a mean age of 47±11 years at the onset of AF (Table 1) . Sixty-six subjects were men (73%), and 57 of the 90 patients had paroxysmal or persistent AF (63%; Table 1 ). Echocardiographic data of the cohort as a whole revealed a normal mean ejection fraction, with a mean left atrial dimension of 40±7 mm ( Table 1) . The 250 control subjects had a mean age of 39±19 years, and 157 of them were men (63%).
Screening for ion-channel variants in genomic DNA in the study cohort of 90 individuals with lone AF identified a total of 7 different variants present in KCNA5 (H463R and T527M), KCNQ1 (L492_E493 ins DL), KCNH2 (T436M and T895M), SCN5A (R986Q), and SCN1B (T189M; Figure 1 ; Table 2 ). SCN1B T189M was detected in 2 probands (1 homozygous and 1
WHAT IS KNOWN
• To date, many variants in genes encoding ion-channel subunits, cardiac gap junctions, and signaling molecules have been identified in monogenic families with atrial fibrillation (AF) and patients with lone AF.
• Few rare variants in AF-associated genes have been functionally characterized to identify a causal relationship between these variants and development of AF.
WHAT THE STUDY ADDS
• We identified 7 rare variants in cardiac ion channels in 8 probands from 90 patients with lone AF, indicating a prevalence of ≈9%.
• These variants were extremely rare and characterized as causing susceptibility to AF by either electrophysiological study or in silico prediction analysis including a new prediction tool, Combined Annotation Dependent Depletion scores.
• More than half of AF-associated rare variants showed gain-of-function behavior, which is likely to benefit from a drug that blocks particular ion channels. heterozygous carrier). The presence of each of these variants was assessed in 250 ethnically matched population control individuals; all variants were rare (MAF, <1%; Table 2 ). According to the ExAC data and browser, the MAFs of KCNA5 T527M, KCNH2 T436M, and SCN5A R986Q were 0.0236%, 0.001627%, and 0.001951%, respectively, which were significantly lower compared with 0.6% in our case population (Table 2) .
Clinical Characteristics and Functional Properties of KCNA5 Variants
The proband who was heterozygous for KCNA5 H463R was a 62-year-old woman with onset of paroxysmal AF at the age of 51 and no family history of AF. She underwent radiofrequency catheter ablation at the age of 61 (Table 3) .
To define the functional effect of the H463R variant, we transiently expressed WT, H463R, and WT+H463R in cultured mammalian HEK293 cells for whole-cell voltage clamp measurements. Voltage clamp recording from cells expressing H463R alone did not exhibit any functional channels, when compared with those expressing WT alone (Figure 2A ; Table 4 ). Coexpression of H463R with WT resulted in a significant current density, which was less than one-third of the control current observed with the expression of WT alone (Figure 2A) .
The current-voltage relationships for activating currents ( Figure 2B ) and tail currents ( Figure 2C ) were recorded during depolarizing pulses. Two-way repeated-measures ANOVA revealed that there was a significant difference in the activating currents and the tail currents ( Figure 2B and 2C) among these 3 channels. The amplitudes of the activating currents at 40 mV and the tail currents at 30 mV for the WT+H463R and the H463R were significantly smaller than those for WT (Figure 2B and 2C; Table I in the Data Supplement). No significant difference in activation kinetics for the WT+H463R was observed compared with WT ( Figure 2D ; Table I in the Data Supplement). In silico analysis predicted that H463R was pathogenic, according to 3 algorithms (Table 5 ). The proband who was heterozygous for KCNA5 T527M was a 51-year-old man, with onset of paroxysmal AF at the age of 49 ( Table 3) . The ECG showed a prolonged PR interval of 220 ms and a normal QTc interval. Monitoring ECG in an outpatient clinic showed a sinus pause of 3.6 s after termination of AF. His son, who also carried the T527M variant in KCNA5, had never experienced AF and had a prolonged PR interval of 220 ms.
HEK293 cells expressing the T527M mutant showed a larger Kv1.5 current than did those expressing WT ( Figure 3A ). Cellular electrophysiological studies showed that the activating current density for T527M was significantly larger than that for WT ( Figure 3B ; Table I in the Data Supplement; Table 4 ). The T527M mutant displayed a negative voltage shift in the normalized activation curve and a significantly decreased the potential when half of the channels were activated, V 1/2 ( Figure 3D ; Table  I in the Data Supplement). In silico analysis using 4 algorithms predicted that T527M was pathogenic (Table 5) .
Clinical Characteristics and Functional Properties of KCNQ1 Variants
The proband who was heterozygous for KCNQ1 L492_E493insDL was a 42-year-old man who was diagnosed with AF on an ECG on routine examination (Table 3) . Because he had no symptoms, the age of onset of paroxysmal AF was unknown. The ECG showed a normal QTc interval at rest and during the late recovery phase of exercise stress testing. His daughter and sons carrying the L492_E493insDL variant in KCNQ1 had never experienced AF and had normal ECGs. Table I in the Data Supplement; Table 4 ). The normalized tail current-voltage relationship for K V 7.1 WT/KCNE1 channels was also similar to that for K V 7.1 mutant/KCNE1 channels ( Figure ID and Table I in the Data Supplement).
Clinical Characteristics and Functional Properties of KCNH2 Variants
The proband who was heterozygous for KCNH2 T436M was a 61-year-old man with onset of AF at the age of 38. The ECG showed chronic AF and a normal QTc interval (Table 3) . His brother and sister had been affected with AF from a young age.
We transiently expressed WT and T436M in cultured mammalian CHO-K1 cells for whole-cell voltage clamp measurements (Figure II in the Data Supplement; Table 4 ). Electrophysiological studies showed that the peak current density for T436M was significantly greater than that for the WT (Figure IIB and Table II in the Data Supplement). No significant difference in activation kinetics or the steadystate inactivation kinetics was observed between the mutant and WT channels (Figure IID and IIF and Table II in the Data Supplement). In contrast, slow and fast time constants in the mutant channel were increased significantly compared with those of the WT (Figure IIE and Table II in the Data  Supplement) . Two-way repeated-measures ANOVA revealed that the fast time constants were significantly increased in the T436M compared with the WT ( Figure IIE in the Data Supplement). In silico prediction analysis indicated that T436M was potentially benign, according to 5 algorithms (Table 5) .
The proband who was heterozygous for KCNH2 T895M was a 58-year-old man with onset of AF at the age of 40 (Table 3) . The ECG showed a normal QTc interval. He underwent radiofrequency catheter ablation at the age of 59. His father, who also carried T895M in KCNH2, had experienced paroxysmal palpitations since his early 50s and developed a transient ischemic attack at the age of 81. The proband's son, who carried the same variant, had also experienced paroxysmal palpitations about once a week since his late 20s.
When we transiently expressed WT and T895M in cultured mammalian CHO-K1 cells for whole-cell voltage clamp measurements, we observed a larger current for the mutant channel than the WT channel ( Figure 4 ). Electrophysiological studies showed that the peak and tail current densities for T895M were significantly larger than those for the WT, respectively (Figure 4B and 4C; Table II in the Data Supplement; Table 4 ). No significant difference in activation kinetics or the steady-state inactivation kinetics when compared with the WT was observed (Figure 4D and 4F; Table II in the Data Supplement). In contrast, both slow and fast deactivation time constants for the mutant channel were increased significantly compared with those of the WT for voltages at −40 and −30 mV ( Figure 4E ; Table II in the Data Supplement). In silico analysis predicted that T895M was likely to be pathogenic, although only according to the score CADD (Table 5) .
Clinical Characteristics and Functional Properties of SCN5A and SCN1B Variants
The proband who was heterozygous for SCN5A R986Q was a 64-year-old man with onset of paroxysmal AF at the age of 58 (Table 3 ). None of his family members had clinical signs of AF. CHO-K1 cells were transiently transfected with vectors expressing WT or R986Q cDNA and the human β1 subunit cDNA in combination with a bicistronic plasmid encoding green fluorescent protein. Compared with the WT, R986Q significantly reduced the peak sodium current density (; Table  4 Figure IIIB and Table III Table III in the Data Supplement). In silico analysis predicted that R986Q was pathogenic, according to 2 algorithms (Table 5) .
SCN1B T189M was detected in 2 probands with lone AF (Table 3) . One proband who was homozygous for the variant was a 59-year-old woman who showed paroxysmal AF with palpitations every few months. Her AF was always terminated soon after taking pilsicainide. Her daughter, who was heterozygous for the variant, was a 33-year-old woman and had never experienced paroxysmal palpitations. The second proband, who was heterozygous for the variant, was a 55-year-old woman who showed paroxysmal AF that was controlled well by pilsicainide. This variant was also detected in a control subject in his 20s. Threonine at 189 is located in the C terminus of the Na V β1 subunit and is highly conserved among the mammalian homologs of this protein. Thus, we performed electrophysiological analysis of the mutant Na V β1 protein. When we coexpressed Na V 1.5 with the mutant Na V β1 subunit, the expressed current density was significantly larger than that observed with the WT Na V β1 subunit ( Figure 5A ; Table 4 ). The maximum peak current density of Na V 1.5 plus Na V β1 T189M, measured at −30 mV, was −463±100 pA/pF, which was significantly smaller than the −240±34 pA/pF for Na V 1.5 plus Na V β1 WT ( Figure 5B ; Table III in the Data Supplement). I-V curves of normalized peak sodium current showed that the mutant channel resulted in a significant negative voltage shift of steady-state activation when compared with the WT channel ( Figure 5C ; Table III in the Data Supplement). No significant difference was observed in the voltage dependence of steady-state fast inactivation ( Figure 5D ; Table III in the Data  Supplement) . In silico analysis predicted that T189M was pathogenic, according to 3 algorithms (Table 5 ).
In Silico Prediction Analysis of Rare Variants Associated With Lone AF
CADD is an integrated algorithm based on a total of 65 annotations; this approach predicted that both KCNA5 variants (H463R and T527M), KCNH2 T895M, SCN5A R986Q, and SCN1B T189M were deleterious (CADD score, >10; Table 5 ). Seven variants were divided into 3 categories on the basis of their cellular electrophysiological profile and CADD scores: (1) cellular electrophysiologically abnormal and bioinformatically deleterious variants, including KCNA5 H463R and T527M, KCNH2 T895M, SCN5A R986Q, and SCN1B T189M; (2) cellular electrophysiologically abnormal and bioinformatically benign variant, including KCNH2 T436M; and (3) cellular electrophysiologically normal but bioinformatically radical variant, including KCNQ1 L492_E493 ins DL ( Figure 6 ). We also investigated how many rare (MAF, <1%) variants were predicted to be deleterious using an in silico prediction tool (CADD scores, >10) and how many such alleles were present in the 12 AF-associated genes, in the largest exome sequencing study to date, using 61 486 unrelated individuals (ExAC data and browser). 12 We found as many as 2255 variants (17 859 alleles) that could potentially be (mis)judged as causative based only on these frequency/ in silico prediction tool strategies ( Figure IV in the Data Supplement).
Discussion
In this study, we analyzed 90 patients with lone AF for rare genetic variants in 12 genes and identified 7 rare variants in 8 patients. This indicates that 8.9% of patients with lone AF carry rare genetic variants. Of these 7 variants, 2 variants were identified in the 250 control subjects (MAF, 0.2% each), 1 variant was reported in the EVS (MAF, <0.01%), and 3 variants were reported in the ExAC (MAF, <0.05% each). More variants were reported in the ExAC than the EVS, likely because the ExAC includes data of east and south Asia, whereas the EVS comprises data of black and European American individuals. Because the MAFs of 3 variants (KCNA5 T527M, KCNH2 T436M, and SCN5A R986Q) in the ExAC database were significantly smaller than those in our case population, these seem to be extremely rare variants. Recently, Olesen et al 17 reported that 29 rare variants had been identified among 192 patients with early-onset lone AF (onset of disease before the age of 40). The frequency of rare variants in our lone AF cohort (8.9%) was lower than that in Olesen's study (15.1%). There are several reasons for the difference in frequency: (1) our cohort included individuals with onset of lone AF at an Figure 5 . Functional characterization of Na V 1.5+Na V β1 T189M in CHO-K1 cells. A, Representative currents generated in CHO-K1 cells that had been transfected with 0.6 μg each of a vector expressing the Na V 1.5 channel and wild-type (WT) Na V β1 subunit (left) or 0.6 μg each of a vector expressing the Na V 1.5 channel and mutant Na V β1 subunit (right). Pulse protocol is shown in the inset. B, I-V relationships for peak currents of Na V 1.5+Na V β1 WT (closed circle, n=16) or Na V 1.5+Na V β1 mutant (closed triangle, n=16). C and D, Voltage dependence of the steady-state activation and fast inactivation of Na V1.5+Na V β1 WT (closed circle, n=16) or Na V 1.5+Na V β1 mutant (closed triangle, n=16), measured using standard pulse protocols.
older age, (2) Olesen et al 17 defined rare variants as variants with an MAF of <0.1% in the EVS, and (3) they performed screening of genomic DNA for 14 genes, whereas 12 genes were investigated in our study.
More than 100 rare variants have been reported in patients with lone AF [7] [8] [9] ; however, the functional effect of most variants has not been evaluated. In this study, we carefully characterized each of the rare variants and could find that they have novel or overt abnormalities in channel function.
One of the 2 KCNA5 variants identified in this study, H463R, was a novel mutation; the histidine at codon 463 is located in the S5-pore loop, in the vicinity of the pore of the K V 1.5 subunit. Our patch clamp study showed that this mutation caused dominant-negative suppression of K V 1.5 WT function and was considered to have a loss-of-function effect. The loss-of-function mutation in the KCNA5 gene can lead to a decrease in I Kur , action potential prolongation, and early after-depolarization. The other KCNA5 variant, T527M, showed a gain-of-function effect with an enhanced steadystate activation, which was revealed by electrophysiological analysis. A previous study reported that 3 gain-of-function variants in KCNA5 displayed a negative voltage shift in the steady-state activation curves. 18 The T527 variant had previously been identified in a Chinese family with AF. 19 We identified 2 KCNH2 variants with gain-of-function effects in patients with lone AF, although only a few KCNH2 variants have so far been reported in patients with lone AF.
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KCNH2 T436M had previously been identified in a long QT syndrome family with low disease penetrance. 21 The proband in our study was affected with AF from the age of 38 and had a number of AF-affected family members. Furthermore, KCNH2 T895M had previously been identified in a patient with sudden infant death syndrome. 22 In our study, the proband's father and son, who both carried the T895M variant, had paroxysmal palpitations. Our cellular electrophysiological studies showed that the deactivation time course in both these K V 11.1 channels were significantly slower than that in the WT channel, which resulted in a gain-of-function effect. A previous study of T895M in Xenopus oocytes showed that the deactivation time constants in the T895M channel were increased significantly compared with those of the WT, 22 which corresponded to our results. The gain-of-function KCNH2 variants implicated in susceptibility to AF may exist more frequently than indicated in previous reports.
Several KCNQ1 gain-of-function mutations have been identified in patients with lone AF to date. 8 We found a KCNQ1 insertion variant (L492_E493insDL) in a lone AF proband with normal QTc intervals. This is a so-called radical variant, which is likely to be pathogenic; however, its channel properties were similar to those of the WT channel.
We found a rare SCN5A variant, R986Q, in patients with lone AF. In a heterologous expression study, R986Q was categorized as a loss-of-function variant and can cause shortening of the refractory period and slowing of conduction. We also identified an SCN1B T189M variant in 2 probands with lone AF and in 1 of 250 control subjects in this study. Previously, several SCN1B variants have been reported in patients with AF and had a loss-of-function effect. 8, 23 Our cellular electrophysiological study showed that T189M was a gain-of-function variant, which was predicted to lower the threshold potential for cellular excitability. This is the first report on an AF-associated SCN1B variant that leads to an increased peak sodium current density and that changes the voltage dependence of the steady-state fast activation of the Na + channel. Moreover, our data indicated that the sodiumchannel blocker pilsicainide was effective for AF in probands with gain-of-function variants in SCN1B.
Many prediction tools are available for predicting a pathogenic or benign status for rare variants identified in patients with various genetic disorders.
14,24, 25 Giudicessi et al 14 tested whether 4 prediction tools-conservation analysis, Grantham values, Sorting Intolerant From Tolerant, and PolyPhen2-have the potential to enhance the classification of rare nonsynonymous single-nucleotide variants in type 1 and 2 long QT syndromes. Their findings supported the potential synergistic utility of these tools to enhance the classification of rare variants; however, their use in isolation in clinical application remains limited. CADD is an attractive prediction tool that uses a total of 65 annotations, including gene models, conservation measures, and ENCODE data summaries. 16 In this study, 5 of 6 variants exhibiting electrophysiological abnormalities were predicted to be pathogenic according to their CADD scores, reinforcing classification of these rare variants as pathogenic in patients with lone AF.
Several clinical applications can be derived from this study. First, at least 9% of patients with lone AF have a rare variant in cardiac ion-channel genes. Four of 7 rare variants implicated in susceptibility to AF showed gain-of-function effects by electrophysiological studies. Second, rare ion-channel variants identified in patients with lone AF have therapeutic implications. 10 In particular, patients with gain-of-function variants are likely to benefit from a drug that enables selective inhibition of mutant channel complexes. A previous study showed the enhanced sensitivity of KCNQ1 gain-of-function mutations for the I Ks selective blocker HMR-1556. 26 In our study, sodium-channel blockers were shown to be effective in patients harboring SCN1B T189M. Similarly, I Kur channel blocking or I Kr channel blocking may be effective for preventing the shortening of action potential duration in patients with KCNA5 T527M or KCNH2 T436M and T895M. Thus, genetic testing of major ion-channel genes for patients with lone AF is therefore significant. In addition, the rare variants annotated as pathogenic by CADD should be evaluated to determine whether they have loss-of-function or gain-of-function effects by electrophysiological studies. Third, several asymptomatic family members with rare variants were identified in this study and may have a risk of developing AF in future. These subjects should be advised to avoid acquired risk factors for the development of AF, and preventive care for reducing these risk factors should be provided.
Study Limitations
This study has several limitations. First, 12 major genes were examined here for rare variants associated with AF and were only a small fraction of potential genes related to AF. Wholeexome sequencing or targeted next-generation sequencing may reveal more variants associated with AF in many genes. Second, the case population (n=90) and the control population (n=250) used in this study were relatively small. Indeed, recent reports studied 192 to 307 patients with lone AF or 216 to 240 healthy subjects as a reference. 18, 27 However, we used data from the EVS 11 and the ExAC data and browser 12 as reference groups. Finally, only the individual variants identified in the cases were evaluated in the control population. It is possible that a series of rare variants may have been identified in the controls if the rest of the coding region of each gene had been fully screened in the controls. In fact, 2255 rare and deleterious variants (MAF, <1%; CADD scores, >10) in 12 AFassociated genes were found in the ExAC data and browser, 12 which comprises in excess of 60 000 unrelated individuals sequenced ( Figure IV in the Data Supplement). This emphasizes the importance of both phenotype assessments and functional analyses for the determination of disease-causing variants even in this comprehensive genotyping era.
Conclusions
In our cohort of patients with lone AF, 7 rare variants in cardiac ion-channel genes were identified in 8 probands, with a prevalence of ≈9%. These variants were extremely rare and characterized as causing susceptibility to AF by either electrophysiological study or in silico prediction analysis. More than half of AF-associated rare variants showed gain-of-function behavior, which is likely to benefit from a drug that blocks particular ion channels.
